A new large‐scale manufacturing platform for complex biopharmaceuticals

…, J Ignowski, S Garger, A Salgotra, J Tom - Biotechnology and …, 2012 - Wiley Online Library
Complex biopharmaceuticals, such as recombinant blood coagulation factors, are addressing
critical medical needs and represent a growing multibillion‐dollar market. For commercial …

Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis

…, P Fontoura, BJ Lee, HEN De Vegvar, J Tom… - Nature …, 2003 - nature.com
The diversity of autoimmune responses poses a formidable challenge to the development of
antigen-specific tolerizing therapy. We developed 'myelin proteome' microarrays to profile …

[HTML][HTML] Prognostic and predictive biomarkers in patients with coronavirus disease 2019 treated with tocilizumab in a randomized controlled trial

J Tom, M Bao, L Tsai, A Qamra, D Summers… - Critical Care …, 2022 - journals.lww.com
OBJECTIVES: To explore candidate prognostic and predictive biomarkers identified in
retrospective observational studies (interleukin-6, C-reactive protein, lactate dehydrogenase, …

[HTML][HTML] LACC1 regulates TNF and IL-17 in mouse models of arthritis and inflammation

…, X Wu, M Sagolla, N Ota, A Wuster, J Tom… - The Journal of …, 2019 - journals.aai.org
Both common and rare genetic variants of laccase domain-containing 1 (LACC1, previously
C13orf31) are associated with inflammatory bowel disease, leprosy, Behcet disease, and …

[HTML][HTML] South Asian medical cohorts reveal strong founder effects and high rates of homozygosity

…, S Schoenherr, Q Bei, T Bhangale, J Tom… - Nature …, 2023 - nature.com
The benefits of large-scale genetic studies for healthcare of the populations studied are well
documented, but these genetic studies have traditionally ignored people from some parts of …

Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a …

…, J Reeder, K Mukhyala, K Cuenco, J Tom… - The Lancet …, 2018 - thelancet.com
Background Idiopathic pulmonary fibrosis (IPF) risk has a strong genetic component. Studies
have implicated variations at several loci, including TERT, surfactant genes, and a single …

[HTML][HTML] Comprehensive genomic analysis identifies pathogenic variants in maturity-onset diabetes of the young (MODY) patients in South India

…, EW Stawiski, KB Pahuja, LD Goldstein, J Tom… - BMC medical …, 2018 - Springer
Background Maturity-onset diabetes of the young (MODY) is an early-onset, autosomal
dominant form of non-insulin dependent diabetes. Genetic diagnosis of MODY can transform …

Cognitive deficits, changes in synaptic function, and brain pathology in a mouse model of normal aging

…, BE Lauffer, HH Lin, SL Dominguez, J Reeder, J Tom… - ENeuro, 2015 - eneuro.org
Age is the main risk factor for sporadic Alzheimer’s disease. Yet, cognitive decline in aged
rodents has been less well studied, possibly due to concomitant changes in sensory or …

[HTML][HTML] Inhaled JAK inhibitor GDC-0214 reduces exhaled nitric oxide in patients with mild asthma: a randomized, controlled, proof-of-activity trial

IE Braithwaite, F Cai, JA Tom, JM Galanter… - Journal of Allergy and …, 2021 - Elsevier
Background The Janus kinase (JAK) pathway mediates the activity of many asthma-relevant
cytokines, including IL-4 and IL-13. GDC-0214 is a potent, inhaled, small-molecule JAK …

[HTML][HTML] Identifying and mitigating batch effects in whole genome sequencing data

JA Tom, J Reeder, WF Forrest, RR Graham… - BMC …, 2017 - Springer
Background Large sample sets of whole genome sequencing with deep coverage are being
generated, however assembling datasets from different sources inevitably introduces batch …